Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
127236531	12723653	1	I	20160728	20160825	20160908	20160908	EXP		GB-AUROBINDO-AUR-APL-2016-10998	AUROBINDO		80.00	YR		M	Y	64.00000	KG	20160908		MD	GB	GB

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
127236531	12723653	1	PS	CIPROFLOXACIN.	CIPROFLOXACIN	1	Oral	500 MG, TWO TIMES A DAY	1000	MG	Y	U			77859	500	MG		BID
127236531	12723653	2	C	LISINOPRIL.	LISINOPRIL	1	Unknown	10 MG, UNK				U			0	10	MG

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
127236531	12723653	1	Urinary tract infection
127236531	12723653	2	Product used for unknown indication

Outcome of event

Event ID	CASEID	OUTC COD
127236531	12723653	OT

Reactions reported

Event ID	CASEID	PT
127236531	12723653	Myositis
127236531	12723653	Pain
127236531	12723653	Rash
127236531	12723653	Tendonitis
127236531	12723653	White blood cell count increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
127236531	12723653	1	20160728	20160816	0